Five Prime Therapeutics - Top 20 VC deals of 2008

Five Prime, Fiercebiotech's top venture capital deals of 2008Company: Five Prime Therapeutics
Based: San Francisco, CA
Amount: $40.28M

Investors: Domain Associates, Versant Ventures, Odlander, Fredrikson & Co., Pfizer, Kleiner Perkins Caufield & Byers, Advanced Technology Ventures

Scoop: Five Prime Therapeutics is using its discovery platform to discover protein and antibody therapeutics. The company screens secreted proteins and receptors using cell-based and in vivo screening systems. It's pipeline includes FP-1030, oncology product in Phase I trials, as well as multiple preclinical and research programs in oncology, metabolic disease and immunology. 

Five Prime Therapeutics - Top 20 VC deals of 2008
Read more on

Suggested Articles

Horizon Therapeutics is expanding its U.S. footprint to the Bay Area—the company unveiled a new R&D and manufacturing site in South San Francisco.

Azeria Therapeutics has raised £32 million ($41 million) to take its estrogen receptor positive breast cancer program into the clinic.

Biogen’s Al Sandrock has given a bullish assessment of Alzheimer’s disease drug aducanumab. The head of R&D at Biogen thinks the drug works, despite i